Delivery Order SPE2DR25D2009-SPE2DR26FJ4E5
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rotarix vaccine oral syringes (1.5mL) with a ceiling value of $12,644.74. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the...
- The Defense Logistics Agency awarded a delivery order valued at $2,486.37 to AmerisourceBergen Drug Corp for Rotarix Vaccine oral syringes (1.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rotarix vaccine oral syringes in 1.5mL units, with a ceiling value of $5,527.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,133.43 to supply Rotarix vaccine in oral syringe format (1.5ML) with a completion date of October 31, 2025. This is a firm fixed price delivery order issued on October 30, 2025, with no set-aside designation, indicating the award was made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,504.45 to AmerisourceBergen Drug Corp for Rotarix Vaccine oral syringes (1.5 mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Rotarix vaccine oral syringes in 1.5mL doses. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,430.08 and is scheduled for completion by December 8, 2025. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,541.07 to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine in oral syringe format (1.5 mL units). This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a competitively awarded non-set-aside contract. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4E5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Rotarix vaccine oral syringes (1.5mL) with a ceiling value of $3,502.30. This firm fixed-price delivery order, with an ultimate completion date of December 15, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime IDC vehicle, this comprehensive global pharmaceutical support contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and medical devices. The company's federal contract portfolio demonstrates consistent capability to fulfill medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/11/25 |